Association of Hepatitis C Virus Infection with Serum Iron Status: Analysis of Data from the Third National Health and Nutrition Examination Survey
Open Access
- 15 March 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 40 (6) , 834-841
- https://doi.org/10.1086/428062
Abstract
Background. There is growing evidence that mildly increased amounts of iron in the liver can increase hepatic injury, particularly if combined with other hepatotoxic factors, such as alcohol use, use of porphyrogenic drugs, or chronic viral hepatitis. In the present study, the association of hepatitis C virus (HCV) infection with serum measurements of iron status was assessed in the US population. Methods. We analyzed data from a total of 14,462 participants in the Third National Health and Nutrition Examination Survey. We excluded subjects who were aged Results. Mean serum levels of ferritin and iron (± standard error) were significantly higher among subjects with HCV infection (100 ± 3 ng/mL and 229 ± 17 µg/dL, respectively) than among subjects without liver disease (83 ± 0.3 ng/mL and 101 ± 2.1 µg/dL, respectively) (P <.0001). Serum levels of ferritin were directly and significantly correlated with serum levels of alanine aminotransferase, aspartate aminotransferase, and γ-glutamyl transpeptidase (r = 0.25, r = 0.24, and r = 0.28, respectively; P <.0001), whereas platelet counts were inversely correlated with serum levels of ferritin (r = -0.12; P <.0001). Conclusion. HCV infection is significantly associated with higher serum levels of ferritin and iron in the US population.Keywords
This publication has 39 references indexed in Scilit:
- Iron as a comorbid factor in chronic viral hepatitisAmerican Journal of Gastroenterology, 2002
- Long term effects of phlebotomy on biochemical and histological parameters of chronic hepatitis CAmerican Journal of Gastroenterology, 2002
- Chronic hepatitis C treated with phlebotomy alone: biochemical and histological outcomeDigestive and Liver Disease, 2001
- Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: A multicenter, prospective, randomized, controlled trialHepatology, 2000
- IRON-INDUCED LIVER INJURYClinics in Liver Disease, 2000
- Iron reduction before and during interferon therapy of chronic hepatitis C: Results of a multicenter, randomized, controlled trialHepatology, 2000
- Iron and Chronic Viral HepatitisHepatology, 1997
- Iron stores, response to α‐interferon therapy, and effects of iron depletion in chronic hepatitis CLiver International, 1996
- Iron in Liver Diseases Other than HemochromatosisSeminars in Liver Disease, 1996
- Response to interferon α therapy is influenced by the iron content of the liverJournal of Hepatology, 1994